MODIFICATION
A -- Production, Analysis, and Distribution of Cannabis and Related Materials - Amendment 1
- Notice Date
- 10/23/2014
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- N01DA-15-7793
- Archive Date
- 9/25/2014
- Point of Contact
- Andrew Hotaling, Phone: (301) 443-6677, Kenneth E Goodling, Phone: (301) 443-6677
- E-Mail Address
-
hotalingar@mail.nih.gov, kg25d@nih.gov
(hotalingar@mail.nih.gov, kg25d@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Amendment No. 01 to NIDA RFP No. N01DA-15-7793 Amendment No. 01 to NIDA RFP No. N01DA-15-7793: To respond to formal questions submitted in response to the solicitation and to amend the RFP. Note: As indicated in Amendment No. 01, Answer 1 (p. 2), Section M.3.D. of the RFP is amended to read as follows: D. The successful offeror and/or the successful offeror's subcontractor responsible for the production/manufacture of cannabis extract drug dosage form and marijuana cigarettes must be registered with the FDA as a pharmaceutical manufacturer for drug dosage forms.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-15-7793/listing.html)
- Record
- SN03556556-W 20141025/141023234147-2a58e20030a50628e34d9e7565de6be4 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |